# Hagerty, Inc.: financial statements, quarterly

HGTY · NYSE · CIK 1840776 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hgty.md) · [Financials](/companies/hgty/financials.md) · [Filings](/companies/hgty/filings.md) · [Insiders](/companies/hgty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hgty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [136](/filings/0001840776-24-000252.md) | [93.6 d](/filings/0001840776-26-000013.md) | [119](/filings/0001840776-25-000143.md) | [153](/filings/0001840776-25-000222.md) | [155](/filings/0001840776-25-000233.md) | [121 d](/filings/0001840776-26-000013.md) | [148](/filings/0001840776-26-000021.md) | [188](/filings/0001840776-26-000031.md) | [190](/filings/0001840776-25-000233.md) | [151 d](/filings/0001840776-26-000013.md) | [61.1](/filings/0001840776-26-000021.md) | [80.8](/filings/0001840776-26-000031.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | [144](/filings/0001840776-26-000021.md) | [162](/filings/0001840776-26-000031.md) | not reported | not reported | [72.4](/filings/0001840776-26-000021.md) | [95.3](/filings/0001840776-26-000031.md) |
| Operating income | $m | [16.1](/filings/0001840776-24-000252.md) | [(6.5) d](/filings/0001840776-25-000033.md) | [12.2](/filings/0001840776-25-000143.md) | [38.1](/filings/0001840776-25-000222.md) | [10.1](/filings/0001840776-25-000233.md) | [6.0 d](/filings/0001840776-25-000033.md) | [25.7](/filings/0001840776-25-000143.md) | [47.7](/filings/0001840776-25-000222.md) | [34.3](/filings/0001840776-25-000233.md) | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.4](/filings/0001840776-26-000021.md) | [1.5](/filings/0001840776-26-000031.md) | not reported | not reported | [1.1](/filings/0001840776-26-000021.md) | [1.2](/filings/0001840776-26-000031.md) |
| Income tax | $m | [4.6](/filings/0001840776-24-000252.md) | [4.6 d](/filings/0001840776-26-000013.md) | [5.1](/filings/0001840776-25-000143.md) | [5.8](/filings/0001840776-25-000222.md) | [(1.0)](/filings/0001840776-25-000233.md) | [5.5 d](/filings/0001840776-26-000013.md) | [5.5](/filings/0001840776-26-000021.md) | [6.2](/filings/0001840776-26-000031.md) | [(32.8)](/filings/0001840776-25-000233.md) | [11.1 d](/filings/0001840776-26-000013.md) | [(8.2)](/filings/0001840776-26-000021.md) | [(5.8)](/filings/0001840776-26-000031.md) |
| Net income | $m | [18.6](/filings/0001840776-24-000252.md) | [9.0 d](/filings/0001840776-26-000013.md) | [8.2](/filings/0001840776-25-000143.md) | [42.7](/filings/0001840776-25-000222.md) | [19.0](/filings/0001840776-25-000233.md) | [8.4 d](/filings/0001840776-26-000013.md) | [27.3](/filings/0001840776-26-000021.md) | [47.2](/filings/0001840776-26-000031.md) | [46.2](/filings/0001840776-25-000233.md) | [28.6 d](/filings/0001840776-26-000013.md) | [(12.7)](/filings/0001840776-26-000021.md) | [8.0](/filings/0001840776-26-000031.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [90.7](/filings/0001840776-24-000252.md) | [108](/filings/0001840776-26-000013.md) | [131](/filings/0001840776-25-000143.md) | [121](/filings/0001840776-25-000222.md) | [147](/filings/0001840776-25-000233.md) | [105](/filings/0001840776-26-000013.md) | [128](/filings/0001840776-26-000021.md) | [140](/filings/0001840776-26-000031.md) | [160](/filings/0001840776-25-000233.md) | [160](/filings/0001840776-26-000031.md) | [212](/filings/0001840776-26-000021.md) | [298](/filings/0001840776-26-000031.md) |
| Current assets | $m | [1,249](/filings/0001840776-23-000168.md) | [1,250](/filings/0001840776-25-000033.md) | [1,245](/filings/0001840776-24-000100.md) | [1,013](/filings/0001840776-24-000175.md) | [1,009](/filings/0001840776-24-000252.md) | [858](/filings/0001840776-25-000233.md) | [998](/filings/0001840776-25-000143.md) | [1,213](/filings/0001840776-25-000222.md) | [1,214](/filings/0001840776-25-000233.md) | not reported | not reported | not reported |
| Total assets | $m | [1,584](/filings/0001840776-23-000168.md) | [1,588](/filings/0001840776-25-000033.md) | [1,570](/filings/0001840776-24-000100.md) | [1,730](/filings/0001840776-24-000175.md) | [1,818](/filings/0001840776-24-000252.md) | [1,709](/filings/0001840776-26-000013.md) | [1,816](/filings/0001840776-25-000143.md) | [2,041](/filings/0001840776-25-000222.md) | [2,152](/filings/0001840776-25-000233.md) | [2,094](/filings/0001840776-26-000031.md) | [2,025](/filings/0001840776-26-000021.md) | [2,148](/filings/0001840776-26-000031.md) |
| Current liabilities | $m | [891](/filings/0001840776-23-000168.md) | [842](/filings/0001840776-25-000033.md) | [849](/filings/0001840776-24-000100.md) | [970](/filings/0001840776-24-000175.md) | [1,001](/filings/0001840776-24-000252.md) | [915](/filings/0001840776-25-000233.md) | [987](/filings/0001840776-25-000143.md) | [1,146](/filings/0001840776-25-000222.md) | [1,216](/filings/0001840776-25-000233.md) | not reported | not reported | not reported |
| Total liabilities | $m | [1,105](/filings/0001840776-23-000168.md) | [1,095](/filings/0001840776-25-000033.md) | [1,065](/filings/0001840776-24-000100.md) | [1,194](/filings/0001840776-24-000175.md) | [1,210](/filings/0001840776-24-000252.md) | [1,101](/filings/0001840776-26-000013.md) | [1,197](/filings/0001840776-25-000143.md) | [1,380](/filings/0001840776-25-000222.md) | [1,437](/filings/0001840776-25-000233.md) | [1,347](/filings/0001840776-26-000031.md) | [1,291](/filings/0001840776-26-000021.md) | [1,414](/filings/0001840776-26-000031.md) |
| Long-term debt | $m | [75.8](/filings/0001840776-23-000168.md) | [131](/filings/0001840776-25-000033.md) | [91.5](/filings/0001840776-24-000100.md) | [98.0](/filings/0001840776-24-000175.md) | [123](/filings/0001840776-24-000252.md) | [106](/filings/0001840776-26-000013.md) | [133](/filings/0001840776-25-000143.md) | [153](/filings/0001840776-25-000222.md) | [104](/filings/0001840776-25-000233.md) | [178](/filings/0001840776-26-000031.md) | [229](/filings/0001840776-26-000021.md) | [216](/filings/0001840776-26-000031.md) |
| Current portion of debt | $m | not reported | [3.7](/filings/0001840776-25-000033.md) | [5.7](/filings/0001840776-24-000100.md) | [1.2](/filings/0001840776-24-000175.md) | [1.6](/filings/0001840776-24-000252.md) | [0.8](/filings/0001840776-25-000233.md) | not reported | not reported | [73.1](/filings/0001840776-25-000233.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [74.3](/filings/0001840776-23-000168.md) | [92.7](/filings/0001840776-25-000033.md) | [93.5](/filings/0001840776-24-000100.md) | [94.4](/filings/0001840776-24-000175.md) | [148](/filings/0001840776-24-000252.md) | [150](/filings/0001840776-26-000013.md) | [163](/filings/0001840776-25-000143.md) | [172](/filings/0001840776-25-000222.md) | [212](/filings/0001840776-25-000233.md) | [221](/filings/0001840776-26-000031.md) | [219](/filings/0001840776-26-000021.md) | [215](/filings/0001840776-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [61.7 d](/filings/0001840776-24-000252.md) | [1.5 d](/filings/0001840776-26-000013.md) | [58.2](/filings/0001840776-25-000143.md) | [64.0 d](/filings/0001840776-25-000222.md) | [67.4 d](/filings/0001840776-25-000233.md) | [(12.6) d](/filings/0001840776-26-000013.md) | [43.8](/filings/0001840776-26-000021.md) | [53.9 d](/filings/0001840776-26-000031.md) | [92.2 d](/filings/0001840776-25-000233.md) | [29.1 d](/filings/0001840776-26-000013.md) | [16.3](/filings/0001840776-26-000021.md) | [170 d](/filings/0001840776-26-000031.md) |
| Capital expenditure | $m | [5.3 d](/filings/0001840776-24-000252.md) | [4.8 d](/filings/0001840776-26-000013.md) | [4.5](/filings/0001840776-25-000143.md) | [7.4 d](/filings/0001840776-25-000222.md) | [5.3 d](/filings/0001840776-25-000233.md) | [4.1 d](/filings/0001840776-26-000013.md) | [5.4](/filings/0001840776-26-000021.md) | [6.2 d](/filings/0001840776-26-000031.md) | [7.0 d](/filings/0001840776-25-000233.md) | [6.0 d](/filings/0001840776-26-000013.md) | [7.7](/filings/0001840776-26-000021.md) | [8.2 d](/filings/0001840776-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [100](/filings/0001840776-22-000080.md) | [100](/filings/0001840776-22-000113.md) | [100](/filings/0001840776-22-000147.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.